Female Hormonal Replacement Therapy Options
CE Information
1.0 CME creditCompletion Time
1 hourAvailable Until
March 7, 2026Posted By
Arkansas Academy of Physician Assistants
Navigate
Overview
Specialties
Endocrinology, Family Medicine, Geriatrics, Obstetrics / Gynecology, Primary Care, and Women's HealthClinical Topics
Menopause and Women's HealthThe most recent guidelines from the North American Menopause Society (NAMS) show that HRT is relatively safe for most women. This presentation will cover the most common treatment options for HRT, including the contraindications to HRT and alternatives for women who do not qualify for HRT.
Learning Objectives
- Compare the available options for estrogen delivery
- Identify 2 groups of women that should NOT be offered HRT
- Discuss hormone replacement therapy and its associated risks
Speakers
Tesa Ivey, APRN is not a native Arkansan but now considers it home. She received a Master’s Degree in Nursing in 2004 from Troy University in Alabama. After practicing as a clinical nurse specialist for several years she went on to further her nursing education at the University of Arkansas for Medical Sciences making her eligible to sit for the Nurse Practitioner Exam in 2009. She was inducted into the nursing honor society, Sigma Theta Tau, in 2003 and also received a Practicum Scholarship awarded by the dean for student excellence that same year. Tesa is board certified as a Women’s Health Nurse Practitioner as well as Inpatient Obstetrics. She is a practicing APN and also provides continuing nursing education in Obstetrics and Gynecology across the state. She has a special interest in Gynecology for the aging woman and is proud to offer her patients care and compassion in a technology-enhanced environment.
CE Information
This activity offers 1.0 CME credit to attendees.
Accredited by AAPA.
This activity has been reviewed by the American Academy of Physician Associates Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 22 AAPA Category 1 CME credits. Approval is valid from 3/26/2025 to 3/7/2026 . PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-2013092.
Activity Content
Registration to this activity includes access to the following supporting materials.
- Female Hormone Replacement Therapy Options (Size: 1.89 MB)
Duration: about 1 hour | Quality: HD
11 questions
Access your certificate